1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,250 | 1,305 | 13:04 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.12.25 | Bure Equity AB: Bure divests holding in Mentice | 192 | GlobeNewswire (Europe) | Bure Equity AB (publ) ("Bure") has signed an agreement to divest 4,037,824 shares in Mentice AB (publ), listed on Nasdaq First North Growth Market.
The buyer is Gulf Offshore Limited, a company controlled... ► Artikel lesen | |
| 06.11.25 | Mentice AB: Mentice publishes the company's interim report for the period July - September 2025 | 174 | GlobeNewswire (Europe) | SIGNIFICANT PROGRESS IN PERFORMANCE AS MARKET ACTIVITY INCREASES
SIGNIFICANT EVENTS DURING THE THIRD QUARTER 2025 (Jul - Sep)• The strategic organizational change announced in June, aimed at aligning... ► Artikel lesen | |
| MENTICE Aktie jetzt für 0€ handeln | |||||
| 21.08.25 | Mentice AB: Mentice receives approximately SEK 31.95 million through oversubscribed rights issue | 175 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA... ► Artikel lesen | |
| 01.08.25 | Mentice AB: Mentice receives an additional Subscription Commitment of 3.4 MSEK in the upcoming Rights Issue | 177 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA... ► Artikel lesen | |
| 31.07.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 31.07.2025 | 353 | Xetra Newsboard | Das Instrument MN2 SE0012673291 MENTICE AB SK -,20 EQUITY wird ex Kapitalmassnahme gehandelt am 31.07.2025 The instrument MN2 SE0012673291 MENTICE AB SK -,20 EQUITY is traded ex capital adjustment on... ► Artikel lesen | |
| 24.07.25 | Mentice AB: Mentice resolves on a rights issue of approximately SEK 31.95 million | 231 | GlobeNewswire (Europe) | The Board of Directors of Mentice AB (publ) ("Mentice" or the "Company"), (Nasdaq First North Premium Growth Market) has today, based on the authorization granted by the annual general meeting on 27... ► Artikel lesen | |
| 24.07.25 | Mentice AB: Mentice publishes the company's interim report for the period April-June 2025 | 195 | GlobeNewswire (Europe) | IMPORTANT STRATEGIC STEPS TAKEN
SIGNIFICANT EVENTS DURING THE SECOND QUARTER 2025 (APR - JUN)Mentice announced a strategic workforce realignment aimed at optimizing its organizational structure and... ► Artikel lesen | |
| 11.07.25 | Mentice AB: Mentice AB Announces Consolidation of Physical Simulation Operations to Strengthen Long-Term Efficiency and Global Service Delivery | 349 | GlobeNewswire (Europe) | Gothenburg, Sweden, July 11, 2025 - Mentice AB (publ), a global leader in simulation solutions for image-guided therapies, today announces the decision to consolidate its research and development (R&D)... ► Artikel lesen | |
| 16.06.25 | Mentice AB: Mentice AB announces the intent for a strategic workforce realignment to enhance focus and operational efficiency and the intent for a rights issue of max 10% of the share capital | 240 | GlobeNewswire (Europe) | Mentice AB (publ), a globally recognized leader in simulation solutions for image-guided interventional therapies, today announces the intent of a strategic workforce realignment and the intent of planning... ► Artikel lesen | |
| 08.05.25 | Mentice AB: Mentice publishes the company's interim report for the period January-March 2025 | 175 | GlobeNewswire (Europe) | STABLE GROWTH AND STRATEGIC CHANGES IN THE FIRST QUARTER
SIGNIFICANT EVENTS DURING THE FIRST QUARTER 2025 (JAN - MAR)Mentice announced a significant order from a top 20 global Med Tech company for 6.5... ► Artikel lesen | |
| 17.04.25 | Mentice AB: Mentice AB Publishes Annual and Sustainability Report for 2024 - Strong finish to 2024 following a transitional year | 258 | GlobeNewswire (Europe) | Mentice AB (publ), Gothenburg - a globally recognized leader in simulation solutions for image-guided interventional therapies, today published its Annual Report and Sustainability Report for 2024.
The... ► Artikel lesen | |
| 13.02.25 | Mentice AB: Mentice publishes the company's year-end report for the period January-December 2024 | 199 | GlobeNewswire (Europe) | STRONG CLOSING QUARTER
SIGNIFICANT EVENTS DURING THE FORTH QUARTER 2024 (OCT - DEC)Mentice announced the recruitment of Frans Venker as new CEO, starting Jan 1, 2025.The order intake during the quarter... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 15,440 | +1,65 % | BERENBERG stuft ECKERT & ZIEGLER auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Eckert & Ziegler mit einem Kursziel von 24 Euro auf "Buy" belassen. Die vorläufigen Zahlen für 2025 hätten beim Umsatz und... ► Artikel lesen | |
| PENUMBRA | 286,40 | -0,69 % | Aktien New York: Gut erholt - Optimismus von TSMC treibt Chip-Branche an | NEW YORK (dpa-AFX) - Optimistische Wachstumsprognosen des taiwanesischen Chip-Giganten TSMC haben den US-Aktienmärkten und vor allem dem Halbleitersektor zu einer soliden Erholung verholfen. TSMC will... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,400 | -2,82 % | DAX-Konzern Siemens Healthineers legt Zahlen vor | Siemens Healthineers startet solide ins neue Geschäftsjahr und bestätigt den Jahresausblick, wird aber vom schwachen Diagnostikgeschäft in China gebremst. Der DAX-Konzern Siemens Healthineers ist mit... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,640 | +0,40 % | Fresenius Medical Care: Ein Neuanfang nach turbulenten Zeiten? | ||
| FRESENIUS | 49,760 | +1,06 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius mit einem Kursziel von 55 Euro auf "Buy" belassen. Die Bad Homburger seien in Verjüngungskur, und der Markt preise... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,740 | +4,89 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,680 | +3,44 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| CARL ZEISS MEDITEC | 27,520 | +0,66 % | ANALYSE-FLASH: Barclays senkt Carl Zeiss Meditec auf 'Equal Weight' | LONDON (dpa-AFX Broker) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 49 auf 32 Euro gesenkt und die Aktien von "Overweight" auf "Equal Weight" abgestuft. Nur... ► Artikel lesen | |
| HEARTFLOW | 27,690 | +6,54 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| GENEDX | 84,35 | +0,32 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,990 | +2,23 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| GERRESHEIMER | 25,660 | +1,99 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Gerresheimer mit einem Kursziel von 34,10 Euro auf "Buy" belassen. Analyst James Vane-Tempest zählt den Spezialverpackungshersteller... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,750 | +2,84 % | 6 Analysts Have This To Say About Alignment Healthcare | ||
| PROGYNY | 21,960 | +0,18 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| HIMS & HERS HEALTH | 19,500 | +0,15 % | BREAKING: Hims & Hers verschärft Preisdruck bei Novo Nordisk - Aktie beschleunigt Talfahrt | Der dänische Biopharma-Riese ist erst seit wenigen Wochen mit seinem Appetitzügler Wegovy als Tablette auf dem US-Markt und sieht sich einem massiven Preisdruck ausgesetzt. Das Telehealth-Unternehmen... ► Artikel lesen |
MENTICE AB gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -1,63 % bei einem Aktienkurs von 1,205 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MENTICE AB finden Sie auf Wallstreet Online.